NEW YORK, Jan. 25, 2021 /PRNewswire/ --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
[email protected]
ProSight Global, Inc. (NYSE: PROS)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of ProSight Global, Inc. (NYSE: PROS) in connection with the proposed acquisition of the Company by TowerBrook Capital Partners L.P. ("TowerBrook"), and Further Global Capital Management ("Further Global"). Under the terms of the merger agreement, affiliates of TowerBrook and Further Global will acquire all outstanding shares of common stock of PROS for $12.85 per share in cash. If you own PROS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/pros/
Inphi Corporation (NASDAQ: IPHI)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Inphi Corporation (NASDAQ: IPHI) in connection with the company's proposed merger with Marvell Technology Group Ltd. ("MRVL"). Under the terms of the agreement, IPHI shareholders will receive $66.00 in cash and 2.323 shares of the newly-combined company for each IPHI share that they own. If you own IPHI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/iphi/
NantKwest, Inc. (NASDAQ: NK)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of NantKwest, Inc. ("NantKwest" or the "Company") (NASDAQ: NK) in connection with the Company's proposed merger with ImmunityBio. Under the terms of the merger agreement, NantKwest will acquire ImmunityBio through a reverse merger pursuant to which, ImmunityBio shareholders will receive a fixed exchange ratio of 0.8190 shares of NantKwest for each share of ImmunityBio owned. If you own NK shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/nk/
Xilinx, Inc. (NASDAQ: XLNX)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Xilinx, Inc. (NASDAQ: XLNX) in connection with the proposed acquisition of the company by Advanced Micro Devices, Inc. ("AMD"). Under the terms of the agreement, XLNX shareholders will receive 1.7234 shares of AMD common stock for each XLNX share that they own, representing implied per-share merger consideration of $159.91 based upon AMD's January 22, 2021 closing price of $92.79. If you own XLNX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/xlnx/
SOURCE WeissLaw LLP
![](https://rt.prnewswire.com/rt.gif?NewsItemId=DC58215&Transmission_Id=202101251537PR_NEWS_USPR_____DC58215&DateId=20210125)
Share this article